Spiriva leads charge for Boehringer
pharmafile | April 23, 2009 | News story | Sales and Marketing |Â Â Boehringer, COPDÂ
Related Content
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European Commission as a …
How will biomarker-led diagnostics reshape respiratory medicine?
By Dr Louise Ryan Murphy, Chronic obstructive pulmonary disease (COPD) is typically diagnosed and assessed …
Five Facts about COPD
1 Chronic obstructive pulmonary disease is a group of progressive lung conditions, principally emphysema and …
